(Total Views: 629)
Posted On: 07/13/2022 8:46:24 PM
Post# of 148878
As far as Novavax's superior technology that the FDA spurned because they're not Pfizer or Moderna --
Their vaccine can be stored at normal refrigerator temperatures. I don't mean an extra-cold pharmacy refrigerator, I mean one like what you have in your kitchen.
Also their efficacy has been measured in various studies at between 80 and 92% efficacy. This includes AFTER the Omicron variant became the dominant one, not BEFORE like the Pfizer and Moderna vaccines.
The Novavax vaccine includes a protein found on the main part of the virus, not just spike proteins. THAT protein is unchanging on all COVID viruses so even if the spike protein mutates even more radically, the Novavax vaccine should still offer some protection.
And, it has been approved in at least 41 other countries in the past year, while the FDA refused to review their data that they submitted last January.
How is this relevant to CYDY?
I think we are seeing the exact same thing with CYDY that we saw with NVAX. The FDA is slow-walking it, deliberately, so that the somewhat useful Paxlovid and the useless Remdesivir can continue to suck up healthcare dollars, meaning big profits for the Big Pharmas.
EDIT: I forgot to mention that the NVAX vaccine protection lasts for at least 18 months. That's based on the clinical trial people, who still have protection against the virus.
Their vaccine can be stored at normal refrigerator temperatures. I don't mean an extra-cold pharmacy refrigerator, I mean one like what you have in your kitchen.
Also their efficacy has been measured in various studies at between 80 and 92% efficacy. This includes AFTER the Omicron variant became the dominant one, not BEFORE like the Pfizer and Moderna vaccines.
The Novavax vaccine includes a protein found on the main part of the virus, not just spike proteins. THAT protein is unchanging on all COVID viruses so even if the spike protein mutates even more radically, the Novavax vaccine should still offer some protection.
And, it has been approved in at least 41 other countries in the past year, while the FDA refused to review their data that they submitted last January.
How is this relevant to CYDY?
I think we are seeing the exact same thing with CYDY that we saw with NVAX. The FDA is slow-walking it, deliberately, so that the somewhat useful Paxlovid and the useless Remdesivir can continue to suck up healthcare dollars, meaning big profits for the Big Pharmas.
EDIT: I forgot to mention that the NVAX vaccine protection lasts for at least 18 months. That's based on the clinical trial people, who still have protection against the virus.
(13)
(0)Scroll down for more posts ▼
